Assessing psychological functioning in metabolic disorders: Validation of the adaptive behavior assessment system, second edition (ABAS-II), and the behavior rating inventory of executive function (BRIEF) for identification of individuals at risk

JIMD Reports

Volumn 21, Issue , 2015, Pages 35-43

  Waisbren, Susan E ^a   He, Jianping ^b   McCarter, Robert ^c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^c GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Beck anxiety inventory; Executive functioning; Metabolic disorder; Newborn screening; Urea cycle disorder

Indexed keywords

EID: 85002281864     PISSN: 21928304     EISSN: 21928312     Source Type: Book Series    
DOI: 10.1007/8904_2014_373     Document Type: Chapter

References (35)

1. Ah Mew N, Krivitzky L, McCarter R, Batshaw M, Tuchman M (2013) Urea cycle disorders consortium of the rare diseases clinical research network. Clinical outcomes of neonatal onset proximal versus distal urea cycle disorders do not differ. J Pediatr 162:324–329
2. Antshel KM, Waisbren SE (2003) Developmental timing of exposure to elevated levels of phenylalanine is associated with ADHD symptom expression. J Abnorm Child Psychol 31:565–574
3. Bayley N (2005) Bayley scales of infant and toddler development, 3rd edn. The Psychological Corporation, San Antonio
4. Beck AT, Steer RA (1993) Beck anxiety inventory manual. Harcourt Brace and Company, San Antonio
5. Beck AT, Steer RA, Brown GK (1996) Manual for the beck depression inventory-II. The Psychological Corporation, San Antonio
6. Beck NM, Johnston JP, Lemke KS, Pogacar P, Phornphutkul C (2011) Rhode Island metabolic newborn screening: the effect of early identification. A case report of argininosuccinic aciduria (ASA). Med Health R I 94:121–123
7. Bosch AM (2006) Classical galactosaemia revisited. J Inherit Metab Dis 29:516–525
8. Brumm VL, Bilder D, Waisbren SE (2010) Psychiatric symptoms and disorders in phenylketonuria. Mol Genet Metab 99(Suppl 1): S59–S63
9. Christ SE, Huijbregts SC, de Sonneville LM, White DA (2010) Executive function in early-treated phenylketonuria: profile and underlying mechanisms. Mol Genet Metab 99(Suppl 1):S22–S32
10. Delis DC, Kramer JH, Kaplan E, Ober BA (2000) California verbal learning test: second edition (CVLT-II). The Psychological Corporation, San Antonio
11. Fridovich-Keil JL, Walter JH (2008) Galactosemia. In: Valle D, Beaudet A, Vogelstein B, Kinzler BW, Antonarakis SE, Ballabio A, Scriver CR (eds) The online metabolic and molecular bases of inherited disease, 9th edn. McGraw-Hill, New York, Chapter 72
12. Gioia GA, Isquith PK, Guy S, Kenworthy L (2000) Behavior rating inventory of executive function (BRIEF). Psychological Assessment Resource, Lutz, FL
13. Gropman AL, Gertz B, Shattuck K, Kahn IL, Seltzer R, Krivitsky L, Van Meter J (2010) Diffusion tensor imaging detects areas of abnormal white matter microstructure in patients with partial ornithine transcarbamylase deficiency. Am J Neuroradiol 31:1719–1723
14. Gyato K, Wray J, Huang ZJ, Yudkoff M, Batshaw ML (2004) Metabolic and neuropsychological phenotype in women heterozygous for ornithine transcarbamylase deficiency. Ann Neurol 55:80–86
15. Harrison PL, Oakland T (2003) Adaptive behavior assessment system – second edition (ABAS-II). The Psychological Corporation, San Antonio
16. Iafolla AK, Thompson RJ Jr, Roe CR (1994) Medium-chain acyl-coenzyme A dehydrogenase deficiency: clinical course in 120 affected children. J Pediatr 124:409–415
17. Krivitzky L, Babikian T, Lee HS, Thomas NH, Burk-Paull KL, Batshaw ML (2009) Intellectual, adaptive, and behavioral functioning in children with urea cycle disorders. Pediatr Res 66:96–101
18. Reynolds CR, Kamphaus RW (2004) Behavior assessment system for children: second edition (BASC-2). AGS Publishing, Circle Pines, MN
19. Scriver CR, Kaufman S (2001) Hyperphenylalaninemias: phenylalanine hydroxylase deficiency. In: Scriver CR, Baudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw Hill, New York, pp 1667–1724
20. Seminara J, Tuchman M, Krivitzky L et al (2010) Establishing a consortium for the study of rare diseases: the urea cycle disorders consortium. Mol Genet Metab 100(Suppl 1):S97–S105
21. Summar M (2001) Current strategies for the management of neonatal urea cycle disorders. J Pediatr 138(1 Suppl):S30–S39
22. Summar ML, Dobbelaere D, Brusilow S, Lee B (2008) Diagnosis, symptoms, frequency and mortality of 260 patients with urea cycle disorders from a 21-year, multicentre study of acute hyperammonaemic episodes. Acta Paediatr 10:1420–1425
23. Tremont G, Halpert S, Javorsky DJ, Stern RA (2000) Differential impact of executive dysfunction on verbal list learning and story recall. Clin Neuropsychol 14:295–302
24. Vockley J, Whiteman DA (2002) Defects of mitochondrial beta-oxidation: a growing group of disorders. Neuromuscul Disord 12:235–246
25. Waisbren SE, Noel K, Fahrbach K, Cella C, Frame D, Dorenbaum A, Levy H (2007) Phenylalanine blood levels and clinical outcomes in phenylketonuria: a systematic literature review and meta-analysis. Mol Genet Metab 92:63–70
26. Waisbren SE, Potter NL, Gordon CM et al (2012) The adult galactosemic phenotype. J Inherit Metab Dis 35:279–286
27. Waisbren SE, Landau Y, Wilson J, Vockley J (2013) Neuropsychological outcomes in fatty acid oxidation disorders: 85 cases detected by newborn screening. Dev Disabil Res Rev 17:260–268
28. Waisbren SE, Rohr F, Anastasoaie V, Brown M, Harris D, Ozonoff A, Petrides S, Wessel A, Levy HL (2014) Maternal phenylketonuria: long-term outcomes in offspring and post-pregnancy maternal characteristics. J Inherit Metab Dis
29. Waisbren S, White DA (2010) Screening for cognitive and social-emotional problems in individuals with PKU: tools for use in the metabolic clinic. Mol Genet Metab 99(Suppl 1):S96–S99
30. Wechsler D (1999) Wechsler abbreviated scale of intelligence (WASI). The Psychological Corporation, San Antonio
31. Wechsler D (2008) Wechsler adult intelligence scale, fourth edition (WAIS-IV). The Psychological Corporation, San Antonio
32. Wechsler D (2003) Wechsler intelligence scale for children, fourth edition (WISC-IV). The Psychological Corporation, San Antonio, TX
33. Wechsler D (2002) The Wechsler preschool and primary scale of intelligence, third edition (WPPSI-III). The Psychological Corporation, San Antonio, TX
34. Weiss LG, Saklofske DH, Prifitera A, Holdnack JA (2006) WISC-IV: advanced clinical interpretation. Academic, Burlington, MA
35. Wilcken B (2010) Expanded newborn screening: reducing harm, assessing benefit. J Inherit Metab Dis 33(Suppl 2): S205–S210